herobanner-homepage

Imagine Everyday Moments With Symptom Relief

You and your doctor can work together to find a medicine that may help improve your symptoms. XELJANZ is a pill approved to treat adults when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or cannot be tolerated with:

Moderate to Severe Rheumatoid Arthritis
Moderate to Severe Ulcerative Colitis
Active Psoriatic Arthritis
Active Ankylosing Spondylitis

XELJANZ is approved to treat patients ages 2 and older when TNF blockers did not work well or could not be tolerated with:

Active Polyarticular Course Juvenile Idiopathic Arthritis
XELJANZ is a pill, not an injection or infusion
pill in hand

patients in focus

A Closer Look at Real Patient Stories

Learn more about real adult XELJANZ patients with moderate to severe rheumatoid arthritis (RA), active psoriatic arthritis (PsA), and moderate to severe ulcerative colitis (UC). They were prescribed XELJANZ after TNF blockers did not work well or could not be tolerated. As ambassadors, they share their treatment stories to remind you that you’re not alone. Individual results may vary. Patient ambassador stories have been developed in partnership with Pfizer.

Hear From Real Patients

Ashley real patient stories

Meet Ashley

Real XELJANZ

RA Patient

Meet Stephanie

Real XELJANZ

UC Patient

Stephanie real patient stories

10 Years in RA

XELJANZ has been prescribed for more than 10 years, since initial approval in 2012, for adults with moderate to severe rheumatoid arthritis.* XELJANZ was approved for use in adults with active psoriatic arthritis* in 2017, adults with moderate to severe ulcerative colitis* in 2018, and adults with active ankylosing spondylitis in 2021.

In 2020, XELJANZ was approved for use in patients ages 2 and older with active polyarticular course juvenile idiopathic arthritis.*

*Indication revised to use in patients who have not responded or cannot tolerate one or more TNF blockers.

https://www.xeljanz.com/global/fragments/first-approved
Metadata
The everyday movements

Hand stretches—along with an RA treatment that works for you—may help your joints.* Watch the video and stretch your hands in style with this 80s rewind.

*Source: Strengthening and stretching with Rheumatoid Arthritis of the hand (SARAH) Study

Watch Now

Getting Started With XELJANZ

I'm Ready To Talk To My Doctor

Explore Discussion Tools

I Need Help Affording My Prescription

View Savings & Support Options Terms and Conditions Apply

I Want Support Resources

Sign Up For XELJANZ+YOU

I’m Ready To Fill My Prescription

Get Started

Molecule graphic

How XELJANZ Works

XELJANZ is a Janus kinase (JAK) inhibitor that helps regulate an overactive immune system. It helps disrupt JAK pathways from inside the cells, which are believed to play a role in inflammation.

Discover Support Resources

Take an active role in your treatment with tools and support resources—delivered directly to you. We’ll start by sending a Welcome Kit in the mail and will follow up with occasional emails containing timely information and lifestyle tips.

Sign Up Now

XELJANZ (tofacitinib) resource support brochures
https://www.xeljanz.com/global/isi